Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Pooper's Profile
Displaying 1-11 of 11 result(s).
Questions And Suggestions
11/26/2017 10:42:30 PM
As far as the SEC… You’re the o
Questions And Suggestions
11/26/2017 10:40:28 PM
So why don’t you answer the quest
Questions And Suggestions
11/26/2017 3:21:57 PM
Well, I have been watch the SFOR bo
ZRFY Zerify Inc
11/23/2017 12:21:59 PM
Thanks. You too!
ZRFY Zerify Inc
11/23/2017 12:05:46 PM
The rapid selling of shares causing
ZRFY Zerify Inc
11/23/2017 11:40:07 AM
Does anybody have any opinions on t
ZRFY Zerify Inc
11/23/2017 10:51:14 AM
Takes all kinds to make a market I
ZRFY Zerify Inc
11/23/2017 10:08:55 AM
God came to me in a dream and told
ZRFY Zerify Inc
11/22/2017 11:05:58 AM
was looking at patent ligation case
ZRFY Zerify Inc
11/22/2017 10:51:13 AM
im a new investor 2 (1)
ZRFY Zerify Inc
11/22/2017 10:36:23 AM
HI everyone

Recent Articles

  • Celebrating 15 Years of Innovation and Service Excellence
  • Reddit, Inc. Securities Class Action: Important Updates for Investors
  • California's Innovative AI Curriculum: Preparing Future Leaders
  • Concerns Rise Over ETH Treasuries Amid Market Volatility
  • Impact of Trump's Tariffs on Developing Nations Explained
  • Aaron Fraser's New Guide Fuels Sponsorship Success for Athletes
  • Investors' Alert: Join the Flywire Corporation Securities Class Action
  • Empowering Attorneys in Miami: SEO for Lawyers Expands Services
  • Challenges in US-Mexico Cooperation on Drug Cartels
  • Michael Cohen Critiques Trump's Radically New Redistricting Plans
  • Dyne Therapeutics Faces Investigation Over Possible Fraud Claims
  • Lockheed Martin Investigated for Potential Securities Issues
  • Investigation Unfolds: Inspire Medical Systems, Inc. Insights
  • Agilon Health Faces Investigation: What Investors Should Know
  • Replimune Group, Inc. Securities Lawsuit: Your Rights Explained
  • Deep Dive into Mereo BioPharma's Recent Investigations and News
  • OpenAI Responds to Demand, Revives GPT-4o After Backlash
  • Thumzup Media Corporation Enhances Strategies for Public Offering
  • Investigation into Barnes & Noble Education Raises Concerns
  • Julia Hartz's Inspiring Journey from TV Executive to CEO
  • Pomerantz Law Firm's Review for Charter Communications Investors
  • Pomerantz Law Firm Investigates Exelixis, Inc. Investor Claims
  • Duolingo Faces Investigation Amid User Engagement Concerns
  • Confluent, Inc. Faces Investigation Over Potential Securities Fraud
  • Investigation Launched on Tronox Holdings plc Amid Concerns
  • Albany International Faces Lawsuit: What Investors Need to Know
  • Uncovering Potential Legal Actions Against Praxis Precision Medicines
  • Anika Therapeutics Under Investigation as Stock Suffers Loss
  • Insight Into NeoGenomics' Ongoing Financial Challenges and Future
  • Exploring the Untapped Potential of America's Energy Reserves
  • Investigation Launched for Neogen Corporation Investors Amid Concerns
  • Novo Nordisk Faces Class Action Over Sales Outlook Adjustments
  • Analyzing the Implications of Trump and Putin's Meeting
  • Quavo Secures Major Funding to Enhance Fraud Prevention Solutions
  • Explore Opportunities in 3D Systems Corporation Securities
  • Class Action Filed Against iRobot Corporation: What You Need to Know
  • Tesla Faces Class Action as It Expands Autonomous Driving Tech
  • Spectrum Pharmaceuticals Faces Class Action Suit Over Misleading Claims
  • Class Action Lawsuit Filed Against CTO Realty Growth, Inc.
  • Lockheed Martin Investors: Your Chance to Join Class Action Suit
  • Important Legal Steps for Neogen Corporation Investors
  • Barbara Corcoran Shares Insights on Trump's Sales Tactics
  • Luminar Technologies Faces Lawsuit: Investors Take Action
  • Navigating the Potential of RxSight Securities Lawsuit
  • Stock Market Analysis: Insight into Current Trends and Highlights
  • Understanding the Class Action Lawsuit Against RxSight, Inc.
  • Faruqi & Faruqi LLP Takes on Altimmune Securities Fraud Case
  • PepGen Investors Advised on Class Action Lawsuit Opportunities
  • Important Class Action Update for Replimune Investors
  • Investor Alert: Rocket Pharmaceuticals Class Action Details
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site